Skip to content
Disclosery

Eversept Partners, LP

Follow

13F filer, CIK 1697013, NEW YORK, NY

Eversept Partners, LP reported $984,662,642 across 57 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-15. Its ten largest share positions make up 58.82% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001697013-25-000005

Period
2025-03-31
Reported value
$985M
Holdings
57
Top 10 weight
58.82%
New
12
Sold out
20

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SNDXadded+3,868,870$47.5M
NBIXnew+167,243$18.5M
PCVXadded+429,482$16.2M
GKOSnew+158,957$15.6M
CYHadded+5,631,020$15.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
GSKreduced-1,038,522-$40.2M
INSPreduced-107,877-$17.2M
VTRSexited-1,272,102-$15.8M
TEVAreduced-831,360-$12.8M
EWexited-170,678-$12.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001697013-25-000005, largest first. % of portfolio is the value over $883,687,039, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 870,193 shares; 2024Q4: 876,766 shares; 2025Q1: 893,721 shares 893,721$126M14.3%+16,955Timeline
GSKGSK PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,057,206 shares; 2024Q4: 3,661,768 shares; 2025Q1: 2,623,246 shares 2,623,246$102M11.5%-1,038,522Timeline
HCAHCA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 129,084 shares; 2024Q4: 175,808 shares; 2025Q1: 152,502 shares 152,502$52.7M5.96%-23,306Timeline
SNDXSYNDAX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,105,313 shares; 2024Q4: 343,400 shares; 2025Q1: 4,212,270 shares 4,212,270$51.7M5.86%+3,868,870Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,050,157 shares; 2024Q4: 1,600,015 shares; 2025Q1: 1,898,804 shares 1,898,804$45.6M5.16%+298,789Timeline
RVTYREVVITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 469,692 shares; 2024Q4: 392,518 shares; 2025Q1: 299,087 shares 299,087$31.6M3.58%-93,431Timeline
HQYHEALTHEQUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 319,078 shares; 2024Q4: 386,697 shares; 2025Q1: 351,976 shares 351,976$31.1M3.52%-34,721Timeline
INSPINSPIRE MED SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 276,270 shares; 2024Q4: 294,302 shares; 2025Q1: 186,425 shares 186,425$29.7M3.36%-107,877Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 445,204 shares; 2024Q4: 678,787 shares; 2025Q1: 547,116 shares 547,116$26.5M2.99%-131,671Timeline
CYHCOMMUNITY HEALTH SYS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,776,455 shares; 2024Q4: 2,827,000 shares; 2025Q1: 8,458,020 shares 8,458,020$22.8M2.58%+5,631,020Timeline
ZIMVIE INCZIMVIE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,070,780 shares; 2024Q4: 2,070,780 shares; 2025Q1: 2,079,380 shares 2,079,380$22.5M2.54%+8,600
TEVATEVA PHARMACEUTICAL INDS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,234,638 shares; 2024Q4: 2,242,125 shares; 2025Q1: 1,410,765 shares 1,410,765$21.7M2.45%-831,360Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 127,588 shares; 2025Q1: 557,070 shares 557,070$21M2.38%+429,482Timeline
BRKRBRUKER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 234,934 shares; 2025Q1: 499,207 shares 499,207$20.8M2.36%+264,273Timeline
CNCCENTENE CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 134,959 shares; 2024Q4: 188,493 shares; 2025Q1: 340,339 shares 340,339$20.7M2.34%+151,846Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 691,232 shares; 2024Q4: 779,998 shares; 2025Q1: 1,377,674 shares 1,377,674$18.6M2.1%+597,676Timeline
NBIXNEUROCRINE BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 167,243 shares 167,243$18.5M2.09%newTimeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 130,949 shares; 2024Q4: 43,703 shares; 2025Q1: 57,489 shares 57,489$17.7M2.01%+13,786Timeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 663,573 shares; 2024Q4: 299,310 shares; 2025Q1: 280,117 shares 280,117$16.4M1.86%-19,193Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 535,405 shares; 2024Q4: 1,980,312 shares; 2025Q1: 2,172,436 shares 2,172,436$16.3M1.84%+192,124Timeline
GKOSGLAUKOS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 158,957 shares 158,957$15.6M1.77%newTimeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 471,355 shares; 2024Q4: 214,952 shares; 2025Q1: 517,021 shares 517,021$15.6M1.77%+302,069Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 869,913 shares; 2024Q4: 490,296 shares; 2025Q1: 816,254 shares 816,254$14.6M1.66%+325,958Timeline
GMEDGLOBUS MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 192,893 shares 192,893$14.1M1.6%newTimeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 564,902 shares; 2024Q4: 719,836 shares; 2025Q1: 696,499 shares 696,499$12.6M1.43%-23,337Timeline
QQQINVESCO QQQ TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 24,003 shares 24,003$11.3M1.27%newTimeline
ALGNALIGN TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 49,277 shares 49,277$7.83M0.89%newTimeline
TFXTELEFLEX INCORPORATEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 61,736 shares; 2025Q1: 56,630 shares 56,630$7.83M0.89%-5,106Timeline
MOHMOLINA HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,588 shares; 2024Q4: not reported; 2025Q1: 23,735 shares 23,735$7.82M0.88%newTimeline
HUMHUMANA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 33,860 shares; 2024Q4: 22,682 shares; 2025Q1: 27,970 shares 27,970$7.4M0.84%+5,288Timeline
ELVELEVANCE HEALTH INC FORMERLYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 19,465 shares; 2024Q4: 29,178 shares; 2025Q1: 15,698 shares 15,698$6.83M0.77%-13,480Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 307,357 shares; 2024Q4: 275,362 shares; 2025Q1: 280,951 shares 280,951$5.75M0.65%+5,589Timeline
GOSSGOSSAMER BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,978,458 shares; 2024Q4: 4,978,458 shares; 2025Q1: 3,896,841 shares 3,896,841$4.29M0.49%-1,081,617Timeline
ZBIOZENAS BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 190,531 shares; 2024Q4: 172,103 shares; 2025Q1: 445,588 shares 445,588$3.52M0.4%+273,485Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,992,504 shares; 2024Q4: 911,025 shares; 2025Q1: 697,710 shares 697,710$3.51M0.4%-213,315Timeline
MERUS N VMERUS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 68,258 shares; 2024Q4: 68,258 shares; 2025Q1: 70,329 shares 70,329$2.96M0.33%+2,071
RGENREPLIGEN CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 163,593 shares; 2024Q4: 54,066 shares; 2025Q1: 18,452 shares 18,452$2.35M0.27%-35,614Timeline
NVAXNOVAVAX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 365,523 shares 365,523$2.34M0.27%newTimeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 137,949 shares; 2024Q4: 571,305 shares; 2025Q1: 150,480 shares 150,480$2.22M0.25%-420,825Timeline
FTREFORTREA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 457,967 shares; 2024Q4: 401,733 shares; 2025Q1: 293,275 shares 293,275$2.21M0.25%-108,458Timeline
89BIO INC89BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 303,731 shares 303,731$2.21M0.25%new
MRVIMARAVAI LIFESCIENCES HLDGS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 336,966 shares; 2024Q4: not reported; 2025Q1: 942,454 shares 942,454$2.08M0.24%newTimeline
AVTRAVANTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 168,369 shares; 2024Q4: 168,369 shares; 2025Q1: 122,823 shares 122,823$1.99M0.23%-45,546Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,668 shares; 2024Q4: 19,252 shares; 2025Q1: 10,840 shares 10,840$1.9M0.21%-8,412Timeline
IFRXINFLARX NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,621,787 shares; 2024Q4: 492,452 shares; 2025Q1: 1,675,978 shares 1,675,978$1.71M0.19%+1,183,526Timeline
AMARIN CORP PLCAMARIN CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 3,309,309 shares; 2024Q4: 1,516,592 shares; 2025Q1: 3,399,204 shares 3,399,204$1.52M0.17%+1,882,612
SUTRO BIOPHARMA INCSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,841,989 shares; 2024Q4: 694,408 shares; 2025Q1: 2,292,261 shares 2,292,261$1.49M0.17%+1,597,853
ITEOS THERAPEUTICS INCITEOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 220,196 shares; 2025Q1: 220,196 shares 220,196$1.31M0.15%0
KPTIKARYOPHARM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 257,154 shares 257,154$962K0.11%newTimeline
XOMAXOMA ROYALTY CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 94,289 shares; 2024Q4: 95,417 shares; 2025Q1: 45,017 shares 45,017$897K0.1%-50,400Timeline
PBYIPUMA BIOTECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,293,257 shares; 2024Q4: 996,102 shares; 2025Q1: 275,788 shares 275,788$816K0.09%-720,314Timeline
ALECALECTOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 332,756 shares; 2024Q4: 200,095 shares; 2025Q1: 617,418 shares 617,418$759K0.09%+417,323Timeline
EHTHEHEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 89,220 shares 89,220$596K0.07%newTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 406,558 shares; 2024Q4: 98,895 shares; 2025Q1: 343,947 shares 343,947$533K0.06%+245,052Timeline
ACIUAC IMMUNE SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 99,313 shares; 2024Q4: not reported; 2025Q1: 100,752 shares 100,752$188K0.02%newTimeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
QQQINVESCO QQQ TR COMput123,600$58M-119,500
SPYSTATE STR SPDR S&P 500 ETF T SHSput76,900$43M+47,100

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VTRSVIATRIS INC1,272,102$15.8Mshares
TLTISHARES TR179,400$15.7Mput
EWEDWARDS LIFESCIENCES CORP170,678$12.6Mshares
DXCMDEXCOM INC148,688$11.6Mshares
GHGUARDANT HEALTH INC276,036$8.43Mshares
AZNASTRAZENECA PLC-SPONS ADR102,661$6.73Mshares
MEDPMEDPACE HLDGS INC19,049$6.33Mshares
XENEXENON PHARMACEUTICALS INC155,540$6.1Mshares
HSICSCHEIN HENRY INC80,303$5.56Mshares
DHRDANAHER CORP DEL22,209$5.1Mshares
PATTERSON COS INCPATTERSON COS INC146,051$4.51Mshares
EOLSEVOLUS INC383,045$4.23Mshares
SUPNSUPERNUS PHARMACEUTICALS105,581$3.82Mshares
2SEVENTY BIO INC COMMON STO…2SEVENTY BIO INC COMMON STOCK1,003,678$2.95Mshares
MREOMEREO BIOPHARMA GROUP PLC777,890$2.72Mshares
ZLABZAI LAB LTD102,930$2.7Mshares
ARQTARCUTIS BIOTHERAPEUTICS INC191,158$2.66Mshares
XRAYDENTSPLY SIRONA INC139,656$2.65Mshares
KARYOPHARM THERAPEUTICS INCKARYOPHARM THERAPEUTICS INC2,088,757$1.41Mshares
ABSIABSCI CORPORATION199,464$523Kshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001697013-25-000005 base2025-05-15acceptance time not in the bulk data set